28 studies found for:    " July 30, 2008":" August 29, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Terminated A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin
22 Completed
Has Results
Evaluation of Open-canal Behind-the-Ear Hearing Aids and Traditional In-the-ear Hearing Aids.
Condition: Hearing Loss
Intervention: Device: Hearing Aid Treatments
23 Completed TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Conditions: HIV;   AIDS;   Oral Contraceptive
Intervention: Drug: TMC278
24 Completed Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen
Condition: HIV
Intervention: Drug: Raltegravir
25 Completed TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.
Condition: HIV
Intervention: Drug: TMC278
26 Completed TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.
Conditions: HIV;   AIDS
Intervention: Drug: Darunavir
27 Terminated
Has Results
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Pain;   Precancerous Condition;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: methadone hydrochloride;   Drug: morphine sulfate;   Drug: oxycodone hydrochloride
28 Completed Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lung Cancer;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: bevacizumab;   Drug: vandetanib;   Other: laboratory biomarker analysis;   Other: pharmacological study

Show previous page of results Previous Page (1-20) Studies Shown (21-28) Next Page
Indicates status has not been verified in more than two years